New trouble with JNJ vaccine is bad news for the stock and worse news for efforts to reach “herd immunity”
July 12, 2021 | Daily JAM, Mid Term | 0 comments
July 12, 2021 | Daily JAM, Mid Term | 0 comments
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.